924
Views
171
CrossRef citations to date
0
Altmetric
Original Article

Evidence-based data on pain relief with antidepressants

Pages 305-316 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Marianna Mazza, Osvaldo Mazza, Costanza Pazzaglia, Luca Padua & Salvatore Mazza. (2010) Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opinion on Pharmacotherapy 11:7, pages 1049-1052.
Read now
Numan Konuk, Ozgur Ortancil, Bora Bostanci, Sibel Kiran & Perihan Sapmaz. (2010) A Comparison of Reboxetine and Amitryptilline in the Treatment of Fibromyalgia Syndrome with Co-morbid Depressive Symptoms: An Open-label Preliminary Study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 20:1, pages 29-37.
Read now
Richard E Harris & Daniel J Clauw. (2008) Newer treatments for fibromyalgia syndrome. Therapeutics and Clinical Risk Management 4:6, pages 1331-1342.
Read now
David A. Fishbain, Michael J. Detke, Joachim Wernicke, Amy S. Chappell & Daniel K. Kajdasz. (2008) The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder. Current Medical Research and Opinion 24:11, pages 3105-3115.
Read now
Daniel J. Clauw. (2008) Mechanistic Studies and Their Implication for the Management of Fibromyalgia Syndrome. Journal of Musculoskeletal Pain 16:1-2, pages 59-66.
Read now
Bilge Evren, Cuneyt Evren & Mine Hosafci Guler. (2006) An open clinical trial of venlafaxine in the treatment of pain, depressive and anxiety symptoms in fibromyalgia. The Pain Clinic 18:2, pages 167-173.
Read now
Thomas F. Finnegan & Hui Lin Pan. (2005) An Update on Pharmacological Actions of Drugs for Neuropathic Pain Treatment. Journal of Neuropathic Pain & Symptom Palliation 1:3, pages 19-34.
Read now
Alex Cahana, Philippe Mavrocordatos, Jos WM Geurts & Gerbrand J Groen. (2004) Do minimally invasive procedures have a place in the treatment of chronic low back pain?. Expert Review of Neurotherapeutics 4:3, pages 479-490.
Read now
Nicholas J Talley. (2002) New and emerging treatments for irritable bowel syndrome and functional dyspepsia. Expert Opinion on Emerging Drugs 7:1, pages 91-98.
Read now

Articles from other publishers (161)

Jin-Sil Yu, Eun-San Kim, Kyoung Sun Park, Yoon Jae Lee, Yeon Cheol Park, Dongwoo Nam, Eun-Jung Kim & In-Hyuk Ha. (2023) Trends in the treatment of fibromyalgia in South Korea between 2011 and 2018: a retrospective analysis of cross-sectional health insurance data. BMJ Open 13:12, pages e071735.
Crossref
Alexandra A Leaney, Jenna R Lyttle, Julian Segan, Donna M Urquhart, Flavia M Cicuttini, Louisa Chou & Anita E Wluka. (2022) Antidepressants for hip and knee osteoarthritis. Cochrane Database of Systematic Reviews 2022:10.
Crossref
Zi-Han Liu, Yu Jin, Wen-Wang Rao, Qinge Zhang, Juan Zhang, Todd Jackson, Zhaohui Su & Yu-Tao Xiang. (2021) The prevalence of painful physical symptoms in major depressive disorder: A systematic review and meta-analysis of observational studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry 111, pages 110372.
Crossref
Renan C. Castillo & Anna McGinnis. 2021. The Mangled Extremity. The Mangled Extremity 213 223 .
Paulin Jirkof & Heidrun Potschka. 2021. Experimental Design and Reproducibility in Preclinical Animal Studies. Experimental Design and Reproducibility in Preclinical Animal Studies 105 126 .
Mohammad Hossein Panahi, Mostafa Mohseni, Razieh Bidhendi Yarandi & Fahimeh Ramezani Tehrani. (2020) A methodological quality assessment of systematic reviews and meta-analyses of antidepressants effect on low back pain using updated AMSTAR. BMC Medical Research Methodology 20:1.
Crossref
Bárbara B. Garrido‐Suárez, Gabino Garrido, Octavio Piñeros & René Delgado‐Hernández. (2019) Mangiferin: Possible uses in the prevention and treatment of mixed osteoarthritic pain. Phytotherapy Research 34:3, pages 505-525.
Crossref
Sudhakar Pachiappan, Sudaroli Murugaiyan & Sabarinath Chandrasekar. (2020) Emerging intervention of antidepressant with DMARD in non-cancerous nociceptive persistent pain associated depression in FCA induced rheumatoid arthritic rats. Brazilian Journal of Pharmaceutical Sciences 56.
Crossref
Eva Skiöldebrand, Cecilia Ley, Ulrika Björklund, Anders Lindahl & Elisabeth Hansson. (2019) Serotonin-evoked cytosolic Ca2+ release and opioid receptor expression are upregulated in articular cartilage chondrocytes from osteoarthritic joints in horses. Veterinary and Animal Science 8, pages 100078.
Crossref
K.M. Chitty, P. Butterworth & P.J. Batterham. (2019) Antidepressant use and its relationship with current symptoms in a population-based sample of older Australians. Journal of Affective Disorders 258, pages 83-88.
Crossref
Miriam R. Robbins. 2019. Contemporary Dental Pharmacology. Contemporary Dental Pharmacology 69 84 .
R. Garrett Key & William S. Breitbart. 2019. Essentials of Interventional Cancer Pain Management. Essentials of Interventional Cancer Pain Management 473 483 .
Robert Delcanho & Chris Peck. (2018) Neuropathic pain: Diagnosis and treatment from the dental clinic to the multidisciplinary pain clinic. Australian Endodontic Journal 44:2, pages 114-124.
Crossref
Mark Dexter & Arun Aggarwal. (2018) Medical, pharmacological and neurosurgical perspectives on trigeminal neuralgia. Australian Endodontic Journal 44:2, pages 136-147.
Crossref
Chad Brummett & Daniel J. Clauw. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine 213 222.e2 .
Paulin Jirkof. (2017) Side effects of pain and analgesia in animal experimentation. Lab Animal 46:4, pages 123-128.
Crossref
Sikarin Upala, Wai Chung Yong & Anawin Sanguankeo. (2016) Bone mineral density is decreased in fibromyalgia syndrome: a systematic review and meta-analysis. Rheumatology International 37:4, pages 617-622.
Crossref
Verica Vasic & Mirko Schmidt. (2017) Resilience and Vulnerability to Pain and Inflammation in the Hippocampus. International Journal of Molecular Sciences 18:4, pages 739.
Crossref
Rui Xue, Ying Li, Xin-Hua He, Zeng-Liang Jin, Shi-Yong Fan, Ting-Ting Zhang, Nuo-Min Li, Li Yuan, Ai-Ping Zheng, Bo-Hua Zhong, Yun-Feng Li & You-Zhi Zhang. (2016) Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors. Journal of Psychopharmacology 31:3, pages 377-386.
Crossref
Alexandra F. Schütter, Julia Tünsmeyer & Sabine B.R. Kästner. (2017) Influence of tramadol on acute thermal and mechanical cutaneous nociception in dogs. Veterinary Anaesthesia and Analgesia 44:2, pages 309-316.
Crossref
Stefano Magni, Marco Parolini, Camilla Della Torre, Luciana Fernandes de Oliveira, Martina Catani, Roberta Guzzinati, Alberto Cavazzini & Andrea Binelli. (2017) Multi-biomarker investigation to assess toxicity induced by two antidepressants on Dreissena polymorpha. Science of The Total Environment 578, pages 452-459.
Crossref
Tory McJunkin, Edward Swing, Kyle Walters & Paul Lynch. 2017. Comprehensive Pain Management in the Rehabilitation Patient. Comprehensive Pain Management in the Rehabilitation Patient 13 21 .
Kenji Miki, Masato Murakami, Hiroshi Oka, Kaname Onozawa, Sadahiro Yoshida & Kenichi Osada. (2016) Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan. Pain 157:9, pages 2089-2096.
Crossref
Thomas Probst, Susanne Neumeier, Jürgen Altmeppen, Michael Angerer, Thomas Loew & Christoph Pieh. (2016) Depressed Mood Differentially Mediates the Relationship between Pain Intensity and Pain Disability Depending on Pain Duration: A Moderated Mediation Analysis in Chronic Pain Patients. Pain Research and Management 2016, pages 1-7.
Crossref
Michael Webster. (2015) Pharmacologic basis for the use of selective norepinephrine reuptake inhibitors for the treatment of neuropathic pain conditions. Mental Health Clinician 5:6, pages 284-288.
Crossref
Frédérique Rodieux, Valérie Piguet, Patricia Berney, Jules Desmeules & Marie Besson. (2015) Pharmacogenetics and analgesic effects of antidepressants in chronic pain management. Personalized Medicine 12:2, pages 163-175.
Crossref
Leonor Gonçalves, Lauren V. Friend & Anthony H. Dickenson. (2015) The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy. European Journal of Pharmacology 749, pages 151-160.
Crossref
Magdalena Zychowska, Ewelina Rojewska, Wioletta Makuch, Barbara Przewlocka & Joanna Mika. (2015) The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain. European Journal of Pharmacology 749, pages 115-123.
Crossref
Daniel J. Clauw. (2015) Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Practice & Research Clinical Rheumatology 29:1, pages 6-19.
Crossref
Daniel J. Clauw. 2015. Rheumatology. Rheumatology 659 670 .
Ryan D. McConn & Magdalena Anitescu. 2015. Fibromyalgia. Fibromyalgia 51 69 .
Eveline Dischkaln Stolz, Diego Rafael Hasse, Gilsane Lino von Poser & Stela M K Rates. (2014) Uliginosin B, a natural phloroglucinol derivative, presents a multimediated antinociceptive effect in mice. Journal of Pharmacy and Pharmacology 66:12, pages 1774-1785.
Crossref
Grace Chen & Elliot Palmer. 2014. Case Studies in Pain Management. Case Studies in Pain Management 214 222 .
. 2014. Case Studies in Pain Management. Case Studies in Pain Management 81 222 .
Karen Amanda Cocksedge, Chantal Simon & Rohit Shankar. (2014) A difficult combination: chronic physical illness, depression, and pain. British Journal of General Practice 64:626, pages 440-441.
Crossref
David A. Fishbain, Brandly Cole, John E. Lewis & Jinrun Gao. (2014) Does Pain Interfere with Antidepressant Depression Treatment Response and Remission in Patients with Depression and Pain? An Evidence-Based Structured Review. Pain Medicine 15:9, pages 1522-1539.
Crossref
Amy Green, Andrew Crawford, Katherine S. Button, Nicola Wiles, Tim J. Peters, David Nutt & Glyn Lewis. (2014) Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial. Journal of Affective Disorders 163, pages 40-46.
Crossref
Bente Danneskiold-Samsøe & Else Marie BartelsDavid A WilliamsDaniel J Clauw. 2014. Novel Insights into the Pathophysiology and Treatment of Fibromyalgia. Novel Insights into the Pathophysiology and Treatment of Fibromyalgia 114 127 .
F. Mateos, C. Valero, J. M. Olmos, B. Casanueva, J. Castillo, J. Martínez, J. L. Hernández & J. González Macías. (2013) Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia. Osteoporosis International 25:2, pages 525-533.
Crossref
José Alves Gurgel, Roberto César Pereira Lima-Júnior, Cristiano Oliveira Rabelo, Breno Bezerra Gomes Pinho Pessoa, Gerly Anne Castro Brito & Ronaldo Albuquerque Ribeiro. (2013) Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation. Revista Brasileira de Psiquiatria 35:4, pages 387-392.
Crossref
Wojciech Leppert. 2013. Neuropathic Pain. Neuropathic Pain 191 204 .
. 2013. Neuropathic Pain. Neuropathic Pain 177 216 .
Roman Cregg, Giovanna Russo, Anthony Gubbay, Ruth Branford & Hiroe Sato. (2013) Pharmacogenetics of analgesic drugs. British Journal of Pain 7:4, pages 189-208.
Crossref
BAOJUAN HAN. (2013) Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome. Experimental and Therapeutic Medicine 6:3, pages 715-720.
Crossref
Desale Yacob & Carlo Di Lorenzo. (2013) How to Deal with Pediatric Functional Gastrointestinal Disorders. Current Pediatrics Reports 1:3, pages 198-205.
Crossref
Rui Xue, Zeng-Liang Jin, Hong-Xia Chen, Li Yuan, Xin-Hua He, Yan-Ping Zhang, Yong-Gang Meng, Jiang-Ping Xu, Jian-Quan Zheng, Bo-Hua Zhong, Yun-Feng Li & You-Zhi Zhang. (2013) Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. European Neuropsychopharmacology 23:7, pages 728-741.
Crossref
Kristine Phillips & Daniel J. Clauw. (2013) Review: Central pain mechanisms in the rheumatic diseases: Future directions. Arthritis & Rheumatism 65:2, pages 291-302.
Crossref
Enrico Bellato, Eleonora Marini, Filippo Castoldi, Nicola Barbasetti, Lorenzo Mattei, Davide Edoardo Bonasia & Davide Blonna. (2012) Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment. Pain Research and Treatment 2012, pages 1-17.
Crossref
Young Hak Roh, Beom Koo Lee, Jung Ho Noh, Joo Han Oh, Hyun Sik Gong & Goo Hyun Baek. (2012) Effect of depressive symptoms on perceived disability in patients with chronic shoulder pain. Archives of Orthopaedic and Trauma Surgery 132:9, pages 1251-1257.
Crossref
Gerald M. Aronoff. (2011) The Evolution of Pain Treatment: Is it all about Money?. Pain Practice 12:4, pages 326-330.
Crossref
Raj Mitra & Stephanie Jones. (2011) Adjuvant Analgesics in Cancer Pain: A Review. American Journal of Hospice and Palliative Medicine® 29:1, pages 70-79.
Crossref
Edith Holsboer-Trachsler & Florian Holsboer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 589 628 .
Ellen M. Lavoie Smith, Marie A. Bakitas, Peter Homel, Mark Piehl, Linda Kingman, Camilo E. Fadul & Marilyn Bookbinder. (2011) Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With Cancer. Journal of Pain and Symptom Management 42:6, pages 822-838.
Crossref
Afton L. Hassett & Daniel J. Clauw. (2011) Does Psychological Stress Cause Chronic Pain?. Psychiatric Clinics of North America 34:3, pages 579-594.
Crossref
M. Späth. (2011) FibromyalgieFibromyalgia. Zeitschrift für Rheumatologie 70:7, pages 573-587.
Crossref
Marina Díaz-Marsá, Nerea Palomares, M. Dolores Morón, Kazuhiro Tajima, Manuel E. Fuentes, Juan José López-Ibor & José Luis Carrasco. (2011) Psychological Factors Affecting Response to Antidepressant Drugs in Fibromyalgia. Psychosomatics 52:3, pages 237-244.
Crossref
W. Schröder, T. M. Tzschentke, R. Terlinden, J. De Vry, U. Jahnel, T. Christoph & R. J. Tallarida. (2011) Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia. Journal of Pharmacology and Experimental Therapeutics 337:1, pages 312-320.
Crossref
Philip J MeaseDaniel J Walker & Karla Alaka. (2011) Evaluation of duloxetine for chronic pain conditions. Pain Management 1:2, pages 159-170.
Crossref
Ki Woong Kim, Ji Won Han, Hyung Joon Cho, Chong Bum Chang, Joon Hyuk Park, Jung Jae Lee, Seok Bum Lee, Sang Cheol Seong & Tae Kyun Kim. (2011) Association Between Comorbid Depression and Osteoarthritis Symptom Severity in Patients with Knee Osteoarthritis. The Journal of Bone and Joint Surgery-American Volume 93:6, pages 556-563.
Crossref
Guillaume Hache, François Coudore, Alain M. Gardier & Bruno P. Guiard. (2011) Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs). Pharmaceuticals 4:2, pages 285-342.
Crossref
Lauren B. Marangell, Daniel J. Clauw, Ernest Choy, Fujun Wang, Scarlett Shoemaker, Laurence Bradley, Philip Mease & Madelaine M. Wohlreich. (2011) Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152:1, pages 31-37.
Crossref
J. de Lecluse. 2011. Rachis et Sports. Rachis et Sports 233 244 .
Rajpreet Bal, Sudhir Diwan & Karina Gritsenko. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine 378 385 .
Lokesh B. Ningegowda & Nagy A. Mekhail. 2011. Rothman Simeone The Spine. Rothman Simeone The Spine 1895 1903 .
Daniel J. Clauw. 2011. Rheumatology. Rheumatology 769 782.e3 .
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1934 2085 .
Cristiano R. Jesse, Ethel A. Wilhelm & Cristina W. Nogueira. (2010) Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology 212:4, pages 513-522.
Crossref
Lesley M. Arnold. (2010) The Pathophysiology, Diagnosis and Treatment of Fibromyalgia. Psychiatric Clinics of North America 33:2, pages 375-408.
Crossref
Angela M. DeVeaugh-Geiss, Suzanne L. West, William C. Miller, Betsy Sleath, Bradley N. Gaynes & Kurt Kroenke. (2010) The Adverse Effects of Comorbid Pain on Depression Outcomes in Primary Care Patients: Results from the Artist Trial. Pain Medicine 11:5, pages 732-741.
Crossref
Geoff A. Bellingham & Philip W.H. Peng. (2010) Duloxetine. Regional Anesthesia and Pain Medicine 35:3, pages 294-303.
Crossref
Philip J. Mease. (2009) Further Strategies for Treating Fibromyalgia: The Role of Serotonin and Norepinephrine Reuptake Inhibitors. The American Journal of Medicine 122:12, pages S44-S55.
Crossref
Daniel J. Clauw. (2009) Fibromyalgia: An Overview. The American Journal of Medicine 122:12, pages S3-S13.
Crossref
Raphael J Leo. (2009) Milnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia. International Journal of Clinical Rheumatology 4:5, pages 507-517.
Crossref
Lesley M. Arnold. (2014) Advances in the Management of Fibromyalgia. CNS Spectrums 14:S8, pages 12-16.
Crossref
Eun-Ho Kang, In-Soo Lee, Sang-Keun Chung, Sang-Yeol Lee, Eui-Jung Kim, Jin-Pyo Hong, Kang-Seob Oh, Jong-Min Woo, Seonwoo Kim, Joo-Eon Park & Bum-Hee Yu. (2009) Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: A randomized, open-labeled trial. Psychiatry Research 169:2, pages 118-123.
Crossref
David A. Williams & Daniel J. Clauw. (2009) Understanding Fibromyalgia: Lessons from the Broader Pain Research Community. The Journal of Pain 10:8, pages 777-791.
Crossref
YORAM SHIR & MARY-ANN FITZCHARLES. (2009) Should Rheumatologists Retain Ownership of Fibromyalgia?. The Journal of Rheumatology 36:4, pages 667-670.
Crossref
Daniel J. Clauw & James Witter. (2009) Pain and rheumatology: Thinking outside the joint. Arthritis & Rheumatism 60:2, pages 321-324.
Crossref
Horst Berzewski. 2009. Der psychiatrische Notfall. Der psychiatrische Notfall 173 185 .
Daniel J. Clauw, Philip Mease, Robert H. Palmer, R. Michael Gendreau & Yong Wang. (2008) Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clinical Therapeutics 30:11, pages 1988-2004.
Crossref
Elizabeth H.B. Lin. (2008) Depression and Osteoarthritis. The American Journal of Medicine 121:11, pages S16-S19.
Crossref
Troels JensenRandy Shelerud. 2008. Clinical Pain Management Second Edition. Clinical Pain Management Second Edition 501 517 .
Daniel J Clauw. (2008) Commentary on the EULAR recommendations for the management of fibromyalgia. Nature Clinical Practice Rheumatology 4:8, pages 392-393.
Crossref
Serge Perrot, Anthony H. Dickenson & Robert M. Bennett. (2008) Fibromyalgia: Harmonizing Science with Clinical Practice Considerations. Pain Practice 8:3, pages 177-189.
Crossref
Serge Perrot, Rose-Marie Javier, Marc Marty, Claire Le Jeunne & Françoise Laroche. (2008) Antidepressant Use in Painful Rheumatic Conditions. Rheumatic Disease Clinics of North America 34:2, pages 433-453.
Crossref
Kristina Leuner & Walter E. Müller. (2008) Trizyklika als Co‐Analgetika. Therapieoption bei chronischen Schmerzen. Pharmazie in unserer Zeit 37:3, pages 220-225.
Crossref
S. Perrot, R.-M. Javier, M. Marty, C. Le Jeunne & F. Laroche. (2008) Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology 47:8, pages 1117-1123.
Crossref
José Diego Yllanes Vizcay, Adrián Cano Prous & Gloria Sarria Quiroga. (2008) Mejoría del dolor articular en un cuadro depresivo concomitante tratado con duloxetina. Psiquiatría Biológica 15:1, pages 23-26.
Crossref
Howard Liss, Donald Liss & Steven Helper. 2008. Interventional Spine. Interventional Spine 871 892 .
Edith Holsboer-Trachsler & Florian Holsboer. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 515 553 .
H. -P. Kapfhammer. 2008. Psychiatrie und Psychotherapie. Psychiatrie und Psychotherapie 1769 1904 .
Hans-Peter Kapfhammer. (2007) Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer SyndromePsychopharmacotherapy in somatoform disorders and functional somatic syndromes. Psychiatrie und Psychotherapie 3:4, pages 153-168.
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Thomas N. Wise, David A. Fishbain & Vicenzio Holder-Perkins. (2007) Painful Physical Symptoms in Depression: A Clinical Challenge. Pain Medicine 8:suppl 2, pages S75-S82.
Crossref
David A. Fishbain. (2007) Duloxetine Status. Pain Medicine 8:suppl 2, pages S25-S26.
Crossref
Lesley M. Arnold. (2007) Duloxetine and Other Antidepressants in the Treatment of Patients with Fibromyalgia. Pain Medicine 8:suppl 2, pages S63-S74.
Crossref
Edward Covington. (2007) Chronic Pain Management in Spine Disorders. Neurologic Clinics 25:2, pages 539-566.
Crossref
Daniel J. Clauw. (2007) Fibromyalgia: Update on Mechanisms and Management. JCR: Journal of Clinical Rheumatology 13:2, pages 102-109.
Crossref
Gary D. Klasser & Reny de Leeuw. (2007) Medication use in a female orofacial pain population. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 103:4, pages 487-496.
Crossref
Áine Carroll. 2009. Clinical Uses of Botulinum Toxins. Clinical Uses of Botulinum Toxins 243 261 .
Karen G. Meighen. (2007) Duloxetine Treatment of Pediatric Chronic Pain and Co-Morbid Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology 17:1, pages 121-127.
Crossref
Toshiaki KOGURE, Takeshi TATSUMI, Hiroko SATO, Katsuhiko ITOH, Nobuyasu SEKIYA, Takao NAMIKI, Katsutoshi TERASAWA & Jun'ichi TAMURA. (2007) Two Cases of Fibromyalgia Syndrome Succesfully Treated with Kampo Medicine. Kampo Medicine 58:1, pages 61-68.
Crossref
Vanja Duric & Kenneth E. McCarson. (2006) Effects of Analgesic or Antidepressant Drugs on Pain- or Stress-Evoked Hippocampal and Spinal Neurokinin-1 Receptor and Brain-Derived Neurotrophic Factor Gene Expression in the Rat. Journal of Pharmacology and Experimental Therapeutics 319:3, pages 1235-1243.
Crossref
Dina Dadabhoy & Daniel J Clauw. (2006) Therapy Insight: fibromyalgia—a different type of pain needing a different type of treatment. Nature Clinical Practice Rheumatology 2:7, pages 364-372.
Crossref
David Fishbain, Kim Berman & Daniel K. Kajdasz. (2006) Duloxetine for neuropathic pain based on recent clinical trials. Current Pain and Headache Reports 10:3, pages 199-204.
Crossref
Lesley M. Arnold. (2006) Management of psychiatric comorbidity in fibromyalgia. Current Psychiatry Reports 8:3, pages 241-245.
Crossref
Judith B. Chapman, Cassandra L. Lehman, Janette Elliott & J. David Clark. (2006) Sleep Quality and the Role of Sleep Medications for Veterans with Chronic Pain. Pain Medicine 7:2, pages 105-114.
Crossref
A. Alonso-Ruiz, C.A. Pereda-Testa, J. Uson-Jaeger, I. Sánchez-Magro, M. Neira-Álvarez & L. Carmona-Ortells. (2006) Fundamentos y evidencias de los antidepresivos y anticonvulsivos en el dolor reumático. Reumatología Clínica 2, pages S18-S22.
Crossref
Steven J Atlas & Anthony Delitto. (2006) Spinal Stenosis. Clinical Orthopaedics & Related Research 443, pages 198-207.
Crossref
Letícia Maria Furlanetto & Marco Antonio Brasil. (2006) Diagnosticando e tratando depressão no paciente com doença clínica. Jornal Brasileiro de Psiquiatria 55:1, pages 8-19.
Crossref
Yves Henrotin, Sylvie Rozenberg, Federico Balagué, Annette Leclerc, Étienne Rouxo, Christine Cedraschie, Avec la collaboration de Marc Marty & Jean-Pierre Valat. (2006) Recommandations européenes (COST B 13) en matiè de prévention et de prise en charge de la lombalgie non spécifique. Revue du Rhumatisme 73, pages S35-S52.
Crossref
NANCY A. ALVAREZ, BRADLEY S. GALER & ARNOLD R. GAMMAITONI. 2006. Cancer Pain. Cancer Pain 123 137 .
Malcolm Lader, Daniel P. Cardinali & S. R. Pandi-PerumalWilfred R. Pigeon, Hyung Park & Michael J. Sateia. 2006. Sleep and Sleep Disorders. Sleep and Sleep Disorders 201 209 .
Thomas N. Wise, Lesley M. Arnold, Vladimir Maletic & David L. Ginsberg. (2014) Management of Painful Physical Symptoms Associated With Depression and Mood Disorders. CNS Spectrums 10:S19, pages 1-16.
Crossref
B. Bannwarth. (2005) Antidépresseurs en rhumatologie : antalgiques ou thymoanaleptiques ?. Revue du Rhumatisme 72:9, pages 761-763.
Crossref
B. Bannwarth. (2005) Antidepressants in rheumatic disorders: do they act as analgesics or antidepressants?. Joint Bone Spine 72:5, pages 351-353.
Crossref
Caroline F. Samer, Valérie Piguet, Pierre Dayer & Jules A. Desmeules. (2005) Polymorphisme génétique et interactions médicamenteuses : leur importance dans le traitement de la douleurGenetic polymorphism and drug interactions: their importance in the treatment of pain. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 52:8, pages 806-821.
Crossref
Heather V. Krell, Andrew F. Leuchter, Ian A. Cook & Michelle Abrams. (2005) Evaluation of Reboxetine, a Noradrenergic Antidepressant, for the Treatment of Fibromyalgia and Chronic Low Back Pain. Psychosomatics 46:5, pages 379-384.
Crossref
Robert L Barkin & Stacie Barkin. (2005) The Role of Venlafaxine and Duloxetine in the Treatment of Depression with Decremental Changes in Somatic Symptoms of Pain, Chronic Pain, and the Pharmacokinetics and Clinical Considerations of Duloxetine Pharmacotherapy. American Journal of Therapeutics 12:5, pages 431-438.
Crossref
Mattias Ekman, Sven Jönhagen, Elke Hunsche & Linus Jönsson. (2005) Burden of Illness of Chronic Low Back Pain in Sweden. Spine 30:15, pages 1777-1785.
Crossref
Dwight L. Evans, Dennis S. Charney, Lydia Lewis, Robert N. Golden, Jack M. Gorman, K. Ranga Rama Krishnan, Charles B. Nemeroff, J. Douglas Bremner, Robert M. Carney, James C. Coyne, Mahlon R. Delong, Nancy Frasure-Smith, Alexander H. Glassman, Philip W. Gold, Igor Grant, Lisa Gwyther, Gail Ironson, Robert L. Johnson, Andres M. Kanner, Wayne J. Katon, Peter G. Kaufmann, Francis J. Keefe, Terence Ketter, Thomas P. Laughren, Jane Leserman, Constantine G. Lyketsos, William M. McDonald, Bruce S. McEwen, Andrew H. Miller, Dominique Musselman, Christopher O’Connor, John M. Petitto, Bruce G. Pollock, Robert G. Robinson, Steven P. Roose, Julia Rowland, Yvette Sheline, David S. Sheps, Gregory Simon, David Spiegel, Albert Stunkard, Trey Sunderland, Paul TibbitsJr.Jr. & William J. Valvo. (2005) Mood Disorders in the Medically Ill: Scientific Review and Recommendations. Biological Psychiatry 58:3, pages 175-189.
Crossref
Thorsten Giesecke, Richard H. Gracely, David A. Williams, Michael E. Geisser, Frank W. Petzke & Daniel J. Clauw. (2005) The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis & Rheumatism 52:5, pages 1577-1584.
Crossref
Olafur Palsson & William E. Whitehead. (2005) Comorbidity Associated With Irritable Bowel Syndrome. Psychiatric Annals 35:4, pages 320-328.
Crossref
Joan E. Broderick, Doerte U. Junghaenel & Joseph E. Schwartz. (2005) Written Emotional Expression Produces Health Benefits in Fibromyalgia Patients. Psychosomatic Medicine 67:2, pages 326-334.
Crossref
David A. Fishbain. (2005) Polypharmacy Treatment Approaches to the Psychiatric and Somatic Comorbidities Found in Patients with Chronic Pain. American Journal of Physical Medicine & Rehabilitation 84:3, pages S56-S63.
Crossref
J. Craig Nelson, Madelaine M. Wohlreich, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin & John S. Kennedy. (2005) Duloxetine for the Treatment of Major Depressive Disorder in Older Patients. The American Journal of Geriatric Psychiatry 13:3, pages 227-235.
Crossref
A.V. Fann, M.A. Preston, P. Bray, N. Mamiya, D.K. Williams, R.D. Skinner & E. Garcia-Rill. (2005) The P50 midlatency auditory evoked potential in patients with chronic low back pain (CLBP). Clinical Neurophysiology 116:3, pages 681-689.
Crossref
Massimiliano Aragona, Lara Bancheri, Donatella Perinelli, Lorenzo Tarsitani, Alessia Pizzimenti, Antonella Conte & Maurizio Inghilleri. (2012) Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder. European Journal of Pain 9:1, pages 33-38.
Crossref
Shih-Jen Tsai. (2005) Possible involvement of brain-derived neurotrophic factor in the antinociceptive effect of antidepressants in neuropathic pain. Medical Hypotheses 65:3, pages 530-533.
Crossref
Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt, Robert K. McNamara, Mark A. Demitrack & Istvan Bitter. (2004) Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European Neuropsychopharmacology 14:6, pages 457-470.
Crossref
Olivier Vitton, Michael Gendreau, Judy Gendreau, Jay Kranzler & Srinivas G. Rao. (2004) A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Human Psychopharmacology: Clinical and Experimental 19:S1, pages S27-S35.
Crossref
Daisuke Mochizucki. (2004) Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Human Psychopharmacology: Clinical and Experimental 19:S1, pages S15-S19.
Crossref
Geoffrey O. Littlejohn. (2004) Balanced treatments for fibromyalgia. Arthritis & Rheumatism 50:9, pages 2725-2729.
Crossref
Lesley M. Arnold, Yili Lu, Leslie J. Crofford, Madelaine Wohlreich, Michael J. Detke, Smriti Iyengar & David J. Goldstein. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis & Rheumatism 50:9, pages 2974-2984.
Crossref
Yuri A. Saito & Jean C. Fox. (2004) Management of functional abdominal pain. Current Treatment Options in Gastroenterology 7:4, pages 279-290.
Crossref
Margaret A Caudill-Slosberg, Lisa M Schwartz & Steven Woloshin. (2004) Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109:3, pages 514-519.
Crossref
Hassan Monfared, James J Sferra & Nagy Mekhail. (2004) The medical management of chronic pain. Foot and Ankle Clinics 9:2, pages 373-403.
Crossref
C. F. Samer, V. Piguet, P. Dayer & J. A. Desmeules. (2004) Analgésie, l’importance du polymorphisme génétique du cytochrome P450 2D6 dans l’individualisation thérapeutique. Douleur et Analgésie 17:2, pages 63-66.
Crossref
Margaret Claire O’Regan & Angela Clow. (2004) Decreased pain tolerance and mood in recreational users of MDMA. Psychopharmacology 173:3-4, pages 446-451.
Crossref
Thorsten Giesecke, Richard H. Gracely, Masilo A. B. Grant, Alf Nachemson, Frank Petzke, David A. Williams & Daniel J. Clauw. (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis & Rheumatism 50:2, pages 613-623.
Crossref
Tatsuo YAMAMOTO. (2004) . The Journal of Japanese Society of Lumbar Spine Disorders 10:1, pages 27-30.
Crossref
Ko Matsudaira, Atsushi Seichi, Takashi Yamazaki, Junji Kishimoto, Katsushi Takeshita & Kozo Nakamura. (2004) Efficacy of tricyclic antidepressant for somatoform pain disorders with chronic lower back and leg pain. The Journal of Japanese Society of Lumbar Spine Disorders 10:1, pages 155-162.
Crossref
Stephan A Schug & Jennifer Morgan. (2004) Treatment of Cancer Pain. American Journal of Cancer 3:4, pages 247-256.
Crossref
Joab Chapman. 2004. The Neurologic Involvement in Systemic Autoimmune Disorders. The Neurologic Involvement in Systemic Autoimmune Disorders 97 105 .
Lisa C Campbell, Daniel J Clauw & Francis J Keefe. (2003) Persistent pain and depression: a biopsychosocial perspective. Biological Psychiatry 54:3, pages 399-409.
Crossref
Steven J. Atlas & Rachel A. Nardin. (2003) Evaluation and treatment of low back pain: An evidence-based approach to clinical care. Muscle & Nerve 27:3, pages 265-284.
Crossref
Tore K Kvien & Kirsten Viktil. (2003) Pharmacotherapy for regional musculoskeletal pain. Best Practice & Research Clinical Rheumatology 17:1, pages 137-150.
Crossref
JOSEPH J. KEENEJR.JR., GAIL T. GALASKO & MARTIN F. LAND. (2003) Antidepressant use in psychiatry and medicine. The Journal of the American Dental Association 134:1, pages 71-79.
Crossref
T. O. C. Kilkens, A. Honig, N. Rozendaal, M. A. Van Nieuwenhoven & R.-J. M. Brummer. (2003) Serotonergic modulators in the treatment of irritable bowel syndrome - influence on psychiatric and gastrointestinal symptoms. Alimentary Pharmacology & Therapeutics 17:1, pages 43-51.
Crossref
Dajie Wang & John T. Farrar. 2003. Encyclopedia of the Neurological Sciences. Encyclopedia of the Neurological Sciences 150 156 .
MarkusJ Schwarz, Martin Offenbaecher, Alexander Neumeister & Manfred Ackenheil. 2003. Developments in Tryptophan and Serotonin Metabolism. Developments in Tryptophan and Serotonin Metabolism 265 275 .
Margaret E. McCahill. 2003. Family Medicine. Family Medicine 300 306 .
M.J. Schwarz, M. Offenbaecher, A. Neumeister, T. Ewert, M. Willeit, N. Praschak-Rieder, J. Zach, M. Zacherl, K. Lossau, R. Weisser, G. Stucki & M. Ackenheil. (2002) Evidence for an Altered Tryptophan Metabolism in Fibromyalgia. Neurobiology of Disease 11:3, pages 434-442.
Crossref
Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, David Kaplan, Subhdeep Virk, Ahmad Hameed & Kari Lockwood. (2002) Does a Preexisting Anxiety Disorder Predict Response to Paroxetine in Irritable Bowel Syndrome?. Psychosomatics 43:6, pages 451-455.
Crossref
André Barkhuizen. (2002) Rational and targeted pharmacologic treatment of fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 261-290.
Crossref
William E. Whitehead, Olafur Palsson & Kenneth R. Jones. (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?. Gastroenterology 122:4, pages 1140-1156.
Crossref
J.A. Desmeules, C. Cedraschi, V. Piguet, A.-F. Allaz & Pierre Dayer. (2002) Advances with analgesics and NSAIDs for the treatment of spinal disorders. Best Practice & Research Clinical Rheumatology 16:1, pages 105-121.
Crossref
Steven P. Cohen & Salahadin Abdi. (2001) New developments in the use of tricyclic antidepressants for the management of pain. Current Opinion in Anaesthesiology 14:5, pages 505-511.
Crossref
Theresa A. Mays. (2001) Antidepressants in the management of cancer pain. Current Pain and Headache Reports 5:3, pages 227-236.
Crossref
. (2001) Current Awareness. Human Psychopharmacology: Clinical and Experimental 16:1, pages 119-124.
Crossref
David A. Fishbain, Robert Cutler, Hubert L. Rosomoff & Renee Steele Rosomoff. (2000) Evidence-Based Data From Animal and Human Experimental Studies on Pain Relief With Antidepressants: A Structured Review. Pain Medicine 1:4, pages 310-316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.